Calamos Advisors’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Calamos Advisors’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-350,000	Closed	-$3.54M	–	1467
2022 Q3	$3.54M	Buy	+350,000	New	+$3.53M	0.02%	773

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Calamos Advisors's ARCK Position: Q4 2022 in Review

Calamos Advisors sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 350,000 shares — an estimated $3.54M sold.

Calamos Advisors first reported a position in ARCK in Q3 2022 and held it in 1 quarter. The position peaked at $3.54M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Calamos Advisors reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Calamos Advisors sold 350,000 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $3.54M.
Calamos Advisors first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q3 2022 and held it in 1 quarter.
Calamos Advisors's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $3.54M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.